Gilead Sciences shares soar after remdesivir drug shows promise against Covid-19

The biotech company’s shares are soaring in pre-market trading on Friday, after its drug remdesivir shows promise in treatment of Covid-19.

Gilead Sciences shares are soaring, up 16% in pre-market trading, with investors optimistic about the stock after its drug remdesivir has shown promise in treating patients with Covid-19.

In a report by Stat News, it mentioned how early impressions from a study at the University of Chicago Medicine showed that almost all severely ill patients treated with the drug rapidly recovered.

‘The best news is that most of our patients have already been discharged, which is great. We’ve only had two patients perish,’ Kathleen Mullane, an infectious disease specialist who is leading the clinical trials at the university hospital in Chicago, said in a video presentation.

Gilead Sciences closed on Thursday at $76 a share, with the stock trading at $89 in pre-market trading as of 12:10 (GMT) on Friday.

It is worth noting that recent clinical trials offer a limited account of the drug’s effectiveness in combating the virus, with similar trials being run at other institutions. Nevertheless, the results offer a glimmer of hope for investors.

‘What we can say at this stage is that we look forward to data from ongoing studies becoming available,’ Gilead Sciences said in a statement.

Mullane, despite her optimism about the early impressions from the study, admitted that it is still too soon to draw too many conclusions about the efficacy of the drug.

‘But certainly when we start [the] drug, we see fever curves falling,’ she said. ‘Fever is now not a requirement for people to go on trial, we do see when patients do come in with high fevers, they do [reduce] quite quickly.’

‘We have seen people come off ventilators a day after starting therapy. So, in that realm, overall our patients have done very well,’ she added.

Wall Street to open higher after success of new drug

Not only is Gilead Sciences shares expected to trade higher on Friday, but the broader market is on track for a higher opening too, as the prospect of a treatment for coronavirus that could help the global economy recover sooner served to boost investor sentiment.

In fact, S&P 500 futures are up more than 3% on Friday, supported by a rally in Asian stocks. Meanwhile, the FTSE 100 and the European Stoxx 600 index are both up 3%.

How to trade stocks with IG

Looking to trade Gilead Sciences and other stocks? Open a live or demo account with IG and buy (long) or sell (short) the asset using derivatives like CFDs in a few easy steps:

  • Create an IG Trading Account or log in to your existing account

  • Enter ‘Gilead Sciences’ in the search bar and select it

  • Choose your position size

  • Click on ‘buy’ or ‘sell’ in the deal ticket

  • Confirm the trade

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

Please see important Research Disclaimer.

React to global volatility

Market volatility continues as coronavirus concerns amplify. Trade with IG and take advantage of:

  • Tight spreads – from just 1 point on major indices, and 2.8 on US crude
  • Guaranteed stops – they’re free to use, and only incur a fee when triggered
  • Round-the-clock assistance – our highly skilled team are available when you need support

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.


Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.